Scientists at the University of Oxford have received regulatory approval to begin human trials of a new vaccine developed in response to the current Ebola outbreak. With no existing treatments for this specific strain, the vaccine is being tested on healthy volunteers to help provide a necessary tool for controlling the spread of the disease in affected regions.